Elekta AB (publ)
F:EJXB

Watchlist Manager
Elekta AB (publ) Logo
Elekta AB (publ)
F:EJXB
Watchlist
Price: 5.065 EUR 0.4%
Market Cap: 1.9B EUR

Operating Margin
Elekta AB (publ)

10.3%
Current
12%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.3%
=
Operating Profit
1.8B
/
Revenue
17.6B

Operating Margin Across Competitors

No Stocks Found

Elekta AB (publ)
Glance View

Market Cap
1.9B EUR
Industry
Health Care

Elekta AB emanates sophistication and precision, standing at the forefront of medical technology. Established in 1972 by Lars Leksell, the Swedish innovator manifests a legacy deeply rooted in advancing oncology and neurosurgery treatment solutions. Elekta's forte lies in crafting state-of-the-art equipment and software that assist medical practitioners in treating complex cancers and brain disorders. Their products, such as the Leksell Gamma Knife and various advanced linear accelerators, showcase their commitment to minimally invasive treatment. By developing cutting-edge systems that refine radiation therapy and radio-surgery, Elekta plays a pivotal role in enhancing patient outcomes, offering more precise targeting of tumors with minimal damage to surrounding healthy tissues. Financially, Elekta thrives through a multi-faceted revenue model that harmoniously blends hardware sales with recurring income from maintenance services, software upgrades, and training. Their business strategy capitalizes on long-term relationships with healthcare providers, ensuring a steady demand for both product innovation and servicing their existing installations. By anchoring its revenue stream in this hybrid fashion, Elekta offers a compelling proposition for shareholders—a blend of resilient cash flow dynamics and growth through groundbreaking technological advancements. As the global healthcare landscape evolves, Elekta's continuous investment in research and development ensures they remain a venerated leader in tackling the world's challenges in cancer care and neurological disorders.

EJXB Intrinsic Value
7.418 EUR
Undervaluation 32%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
10.3%
=
Operating Profit
1.8B
/
Revenue
17.6B
What is the Operating Margin of Elekta AB (publ)?

Based on Elekta AB (publ)'s most recent financial statements, the company has Operating Margin of 10.3%.

Back to Top